Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;13(9):777-84.
doi: 10.1097/GIM.0b013e31822c79f9.

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities

Erin B Kaminsky  1 , Vineith Kaul, Justin Paschall, Deanna M Church, Brian Bunke, Dawn Kunig, Daniel Moreno-De-Luca, Andres Moreno-De-Luca, Jennifer G Mulle, Stephen T Warren, Gabriele Richard, John G Compton, Amy E Fuller, Troy J Gliem, Shuwen Huang, Morag N Collinson, Sarah J Beal, Todd Ackley, Diane L Pickering, Denae M Golden, Emily Aston, Heidi Whitby, Shashirekha Shetty, Michael R Rossi, M Katharine Rudd, Sarah T South, Arthur R Brothman, Warren G Sanger, Ramaswamy K Iyer, John A Crolla, Erik C Thorland, Swaroop Aradhya, David H Ledbetter, Christa L Martin
Affiliations

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities

Erin B Kaminsky et al. Genet Med. 2011 Sep.

Abstract

Purpose: Copy number variants have emerged as a major cause of human disease such as autism and intellectual disabilities. Because copy number variants are common in normal individuals, determining the functional and clinical significance of rare copy number variants in patients remains challenging. The adoption of whole-genome chromosomal microarray analysis as a first-tier diagnostic test for individuals with unexplained developmental disabilities provides a unique opportunity to obtain large copy number variant datasets generated through routine patient care.

Methods: A consortium of diagnostic laboratories was established (the International Standards for Cytogenomic Arrays consortium) to share copy number variant and phenotypic data in a central, public database. We present the largest copy number variant case-control study to date comprising 15,749 International Standards for Cytogenomic Arrays cases and 10,118 published controls, focusing our initial analysis on recurrent deletions and duplications involving 14 copy number variant regions.

Results: Compared with controls, 14 deletions and seven duplications were significantly overrepresented in cases, providing a clinical diagnosis as pathogenic.

Conclusion: Given the rapid expansion of clinical chromosomal microarray analysis testing, very large datasets will be available to determine the functional significance of increasingly rare copy number variants. This data will provide an evidence-based guide to clinicians across many disciplines involved in the diagnosis, management, and care of these patients and their families.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949–951. - PubMed
    1. IHGSC. Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931–945. - PubMed
    1. Church DM, Lappalainen I, Sneddon TP, et al. Public data archives for genomic structural variation. Nat Genet. 2010;42:813–814. - PMC - PubMed
    1. Boyle CA, Boulet S, Schieve LA, et al. Trends in the Prevalence of Developmental Disabilities in US Children, 1997–2008. Pediatrics. 2011;127:1034–1042. - PubMed
    1. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–764. - PMC - PubMed

Publication types

-